Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517725
Status:
COMPLETED
Last Update Posted:
2010-09-16
First Post:
2007-08-16
Brief Title:
Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure
Sponsor:
Centro Cardiologico Monzino
Organization:
Centro Cardiologico Monzino
Study Overview
Official Title:
Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure Effects on Exercise Capacity and Hypoxia Chemoreceptor Response Pulmonary Function
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CARNEBI
Brief Summary:
The investigators test the hypothesis that different beta-blockers had a different influence on chemoreceptor response and lung diffusion capacity
Both could influence exercise capacity in normoxic as well as hypoxic conditions
Both could influence exercise capacity in normoxic as well as hypoxic conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None